Table 4.
Overall survival of patients after BK-UM administration
| Patient no. | Conventional chemotherapy after BK-UM | Overall survival (months) |
|---|---|---|
| 1 | CDDP + CPT-11 (6 courses) | 28.1 |
| 2 | – | 3.4 |
| 3 | CDDP + CPT-11 (6 courses) | 24.3 |
| 4 | CDDP + CPT-11 (6 courses) | 15.1 |
| 5 | – | 5.5 |
| 6 | – | 5.0 |
| 7 | CDDP + CPT-11 (2 courses) | 7.4 |
| 8 | CDDP + IFM (2 courses) | 4.2 |
| 9 | – | 3.6 |
| 10 | CPT-11 (6 courses) | 14.0 |
| 11 | CBDCA + Doxil (6 courses) | >60a |
CDDP cisplatin, CPT-11 irinotecan, IFM Ifosfamide, CBDCA carboplatin, Doxil doxorubicin hydrochloride liposome injection
aPatient alive at 11/1/2016